Trial intelligence / Profile preview

Intra-articular triamcinolone acetonide 10 mg versus 40 mg for knee osteoarthritis

TCTR20210224002Phase 3Recruiting

Sponsor
Phramongkutklao College of Medicine
Start
Sep 2019
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of triamcinolone acetonide in osteoarthritis (OA) (2 arms), sponsored by Phramongkutklao College of Medicine. Started Sep 2019; status: recruiting.

02

Drugs

triamcinolone acetonide
03

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on TCTR20210224002.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20210224002.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call